skullcapflavone ii has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliakbari, F; Bardania, H; Farhadpour, M; Hourfar, H; Mohammadi, M; Morshedi, D; Najarzadeh, Z; Parsafar, S; Seyedfatemi, SS | 1 |
1 other study(ies) available for skullcapflavone ii and Parkinson Disease
| Article | Year |
|---|---|
Insights into the inhibitory mechanism of skullcapflavone II against α-synuclein aggregation and its mediated cytotoxicity.
Topics: alpha-Synuclein; Flavonoids; Humans; Parkinson Disease | 2022 |